|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-6-4
|
|
pubmed:abstractText |
A comprehensive haplotype analysis of UGT1A1 in the Japanese population was conducted, and the effects of these haplotypes were investigated with respect to UGT1A1-related phenotypic parameters in patients with cancer who received irinotecan.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
pubmed-author:HasegawaRyuichiR,
pubmed-author:JinnoHidetoH,
pubmed-author:KamakuraShiroS,
pubmed-author:KamataniNaoyukiN,
pubmed-author:KaniwaNahokoN,
pubmed-author:KatoriNorikoN,
pubmed-author:KitakazeMasafumiM,
pubmed-author:KitamuraYutakaY,
pubmed-author:KomamuraKazuoK,
pubmed-author:MinamiHironobuH,
pubmed-author:OhtsuAtsushiA,
pubmed-author:OzawaShogoS,
pubmed-author:SaekiMayumiM,
pubmed-author:SaiKimieK,
pubmed-author:SaijoNagahiroN,
pubmed-author:SaitoYoshiroY,
pubmed-author:SawadaJun-ichiJ,
pubmed-author:ShiraoKuniakiK,
pubmed-author:UenoKazuyukiK,
pubmed-author:YoshidaTeruhikoT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
75
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
501-15
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15179405-Aged,
pubmed-meshheading:15179405-Bilirubin,
pubmed-meshheading:15179405-Camptothecin,
pubmed-meshheading:15179405-Female,
pubmed-meshheading:15179405-Genetic Linkage,
pubmed-meshheading:15179405-Glucuronides,
pubmed-meshheading:15179405-Glucuronosyltransferase,
pubmed-meshheading:15179405-Haplotypes,
pubmed-meshheading:15179405-Humans,
pubmed-meshheading:15179405-Japan,
pubmed-meshheading:15179405-Male,
pubmed-meshheading:15179405-Middle Aged,
pubmed-meshheading:15179405-Neoplasms,
pubmed-meshheading:15179405-Polymorphism, Single Nucleotide
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.
|
|
pubmed:affiliation |
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan. sai@nihs.go.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
